Connection

Peter Kalivas to Humans

Back to Details
This is a "connection" page, showing publications Peter Kalivas has written about Humans.
Peter Kalivas
Connection Strength
1.035
Humans
  1. Novelty-induced locomotor behavior predicts heroin addiction vulnerability in male, but not female, rats. Psychopharmacology (Berl). 2022 Nov; 239(11):3605-3620.
    View in: PubMed
    Score: 0.032
  2. Relapse-Associated Transient Synaptic Potentiation Requires Integrin-Mediated Activation of Focal Adhesion Kinase and Cofilin in D1-Expressing Neurons. J Neurosci. 2020 10 28; 40(44):8463-8477.
    View in: PubMed
    Score: 0.028
  3. Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date. Drugs. 2020 Oct; 80(15):1509-1524.
    View in: PubMed
    Score: 0.028
  4. Understanding the Munchies. Neuron. 2020 07 08; 107(1):11-13.
    View in: PubMed
    Score: 0.027
  5. N-acetylcysteine for the treatment of comorbid alcohol use disorder and posttraumatic stress disorder: Design and methodology of a randomized clinical trial. Contemp Clin Trials. 2020 04; 91:105961.
    View in: PubMed
    Score: 0.026
  6. Opposing Regulation of Cocaine Seeking by Glutamate and GABA Neurons in the Ventral Pallidum. Cell Rep. 2020 02 11; 30(6):2018-2027.e3.
    View in: PubMed
    Score: 0.026
  7. Reply to: N-Acetylcysteine in Treatment of Substance Use Disorders. Biol Psychiatry. 2019 06 01; 85(11):e61.
    View in: PubMed
    Score: 0.024
  8. Metaplasticity at the addicted tetrapartite synapse: A common denominator of drug induced adaptations and potential treatment target for addiction. Neurobiol Learn Mem. 2018 10; 154:97-111.
    View in: PubMed
    Score: 0.023
  9. Corticostriatal plasticity, neuronal ensembles, and regulation of drug-seeking behavior. Prog Brain Res. 2017; 235:93-112.
    View in: PubMed
    Score: 0.022
  10. Glutamate Transport: A New Bench to Bedside Mechanism for Treating Drug Abuse. Int J Neuropsychopharmacol. 2017 10 01; 20(10):797-812.
    View in: PubMed
    Score: 0.022
  11. The Direct and Indirect Pathways of the Nucleus Accumbens are not What You Think. Neuropsychopharmacology. 2017 01; 42(1):369-370.
    View in: PubMed
    Score: 0.021
  12. A Double-Blind, Randomized, Controlled Pilot Trial of N-Acetylcysteine in Veterans With Posttraumatic Stress Disorder and Substance Use Disorders. J Clin Psychiatry. 2016 Nov; 77(11):e1439-e1446.
    View in: PubMed
    Score: 0.021
  13. The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate Homeostasis. Pharmacol Rev. 2016 07; 68(3):816-71.
    View in: PubMed
    Score: 0.021
  14. The good and bad news about glutamate in drug addiction. J Psychopharmacol. 2016 11; 30(11):1095-1098.
    View in: PubMed
    Score: 0.020
  15. Signals from the Fourth Dimension Regulate Drug Relapse. Trends Neurosci. 2016 07; 39(7):472-485.
    View in: PubMed
    Score: 0.020
  16. Corticostriatal circuitry in regulating diseases characterized by intrusive thinking. Dialogues Clin Neurosci. 2016 Mar; 18(1):65-76.
    View in: PubMed
    Score: 0.020
  17. The tetrapartite synapse: Extracellular matrix remodeling contributes to corticoaccumbens plasticity underlying drug addiction. Brain Res. 2015 Dec 02; 1628(Pt A):29-39.
    View in: PubMed
    Score: 0.019
  18. Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders. CNS Neurol Disord Drug Targets. 2015; 14(6):745-56.
    View in: PubMed
    Score: 0.018
  19. "Mourning" a lost opportunity. Psychopharmacology (Berl). 2014 Oct; 231(19):3921-2.
    View in: PubMed
    Score: 0.018
  20. Astrocytic dysfunction and addiction: consequences of impaired glutamate homeostasis. Neuroscientist. 2014 Dec; 20(6):610-22.
    View in: PubMed
    Score: 0.017
  21. Rapid, transient synaptic plasticity in addiction. Neuropharmacology. 2014 Jan; 76 Pt B:276-86.
    View in: PubMed
    Score: 0.016
  22. Bipolar disorder and substance misuse: pathological and therapeutic implications of their comorbidity and cross-sensitisation. Br J Psychiatry. 2013 Mar; 202(3):172-6.
    View in: PubMed
    Score: 0.016
  23. Getting to the core of addiction: hatching the addiction egg. Nat Med. 2012 Apr 05; 18(4):502-3.
    View in: PubMed
    Score: 0.015
  24. Substance abuse disorders. Handb Clin Neurol. 2012; 106:419-31.
    View in: PubMed
    Score: 0.015
  25. New medications for drug addiction hiding in glutamatergic neuroplasticity. Mol Psychiatry. 2011 Oct; 16(10):974-86.
    View in: PubMed
    Score: 0.014
  26. Drug wanting: behavioral sensitization and relapse to drug-seeking behavior. Pharmacol Rev. 2011 Jun; 63(2):348-65.
    View in: PubMed
    Score: 0.014
  27. Combining traditional neuroscience disciplines to promote academic growth: the creation of a department of neurosciences. J S C Med Assoc. 2010 Dec; 106(7):248-53.
    View in: PubMed
    Score: 0.014
  28. Using glutamate homeostasis as a target for treating addictive disorders. Behav Pharmacol. 2010 Sep; 21(5-6):514-22.
    View in: PubMed
    Score: 0.014
  29. Group II metabotropic glutamate receptors (mGlu2/3) in drug addiction. Eur J Pharmacol. 2010 Aug 10; 639(1-3):115-22.
    View in: PubMed
    Score: 0.013
  30. The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci. 2009 Aug; 10(8):561-72.
    View in: PubMed
    Score: 0.013
  31. Perspective: the manifest destiny of cocaine research. Neuropsychopharmacology. 2009 Apr; 34(5):1089-90.
    View in: PubMed
    Score: 0.012
  32. Glutamate and reinstatement. Curr Opin Pharmacol. 2009 Feb; 9(1):59-64.
    View in: PubMed
    Score: 0.012
  33. The role of cystine-glutamate exchange in nicotine dependence in rats and humans. Biol Psychiatry. 2009 May 15; 65(10):841-5.
    View in: PubMed
    Score: 0.012
  34. Neuroscience: Brain's defence against cocaine. Nature. 2008 Oct 09; 455(7214):743-4.
    View in: PubMed
    Score: 0.012
  35. Addiction as a pathology in prefrontal cortical regulation of corticostriatal habit circuitry. Neurotox Res. 2008 Oct; 14(2-3):185-9.
    View in: PubMed
    Score: 0.012
  36. Glutamate transmission in addiction. Neuropharmacology. 2009; 56 Suppl 1:169-73.
    View in: PubMed
    Score: 0.012
  37. Neuropharmacology of addiction--setting the scene. Br J Pharmacol. 2008 May; 154(2):259-60.
    View in: PubMed
    Score: 0.012
  38. Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology. 2008 Jan; 33(1):166-80.
    View in: PubMed
    Score: 0.011
  39. Neurobiology of cocaine addiction: implications for new pharmacotherapy. Am J Addict. 2007 Mar-Apr; 16(2):71-8.
    View in: PubMed
    Score: 0.011
  40. Cocaine and amphetamine-like psychostimulants: neurocircuitry and glutamate neuroplasticity. Dialogues Clin Neurosci. 2007; 9(4):389-97.
    View in: PubMed
    Score: 0.011
  41. Animal models and brain circuits in drug addiction. Mol Interv. 2006 Dec; 6(6):339-44.
    View in: PubMed
    Score: 0.011
  42. Exciting inhibition in psychostimulant addiction. Trends Neurosci. 2006 Nov; 29(11):610-6.
    View in: PubMed
    Score: 0.010
  43. How do we determine which drug-induced neuroplastic changes are important? Nat Neurosci. 2005 Nov; 8(11):1440-1.
    View in: PubMed
    Score: 0.010
  44. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry. 2005 Aug; 162(8):1403-13.
    View in: PubMed
    Score: 0.010
  45. Behavioral and neurochemical phenotyping of Homer1 mutant mice: possible relevance to schizophrenia. Genes Brain Behav. 2005 Jul; 4(5):273-88.
    View in: PubMed
    Score: 0.010
  46. Activation of orbital and medial prefrontal cortex by methylphenidate in cocaine-addicted subjects but not in controls: relevance to addiction. J Neurosci. 2005 Apr 13; 25(15):3932-9.
    View in: PubMed
    Score: 0.009
  47. Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission. Neuron. 2005 Mar 03; 45(5):647-50.
    View in: PubMed
    Score: 0.009
  48. Recent understanding in the mechanisms of addiction. Curr Psychiatry Rep. 2004 Oct; 6(5):347-51.
    View in: PubMed
    Score: 0.009
  49. Novel ideas about novelty. Commentary on Badiani and Robinson drug-induced neurobehavioral plasticity: the role of environmental context. Behav Pharmacol. 2004 Sep; 15(5-6):373-6.
    View in: PubMed
    Score: 0.009
  50. Last call for adenosine transporters. Nat Neurosci. 2004 Aug; 7(8):795-6.
    View in: PubMed
    Score: 0.009
  51. Choose to study choice in addiction. Am J Psychiatry. 2004 Feb; 161(2):193-4.
    View in: PubMed
    Score: 0.009
  52. Glutamate systems in cocaine addiction. Curr Opin Pharmacol. 2004 Feb; 4(1):23-9.
    View in: PubMed
    Score: 0.009
  53. Glutamate transmission and addiction to cocaine. Ann N Y Acad Sci. 2003 Nov; 1003:169-75.
    View in: PubMed
    Score: 0.009
  54. AGS3: a G-Protein regulator of addiction-associated behaviors. Ann N Y Acad Sci. 2003 Nov; 1003:356-7.
    View in: PubMed
    Score: 0.009
  55. Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (Berl). 2003 Jul; 168(1-2):44-56.
    View in: PubMed
    Score: 0.008
  56. Predisposition to addiction: pharmacokinetics, pharmacodynamics, and brain circuitry. Am J Psychiatry. 2003 Jan; 160(1):1-2.
    View in: PubMed
    Score: 0.008
  57. The temporal sequence of changes in gene expression by drugs of abuse. Methods Mol Med. 2003; 79:3-11.
    View in: PubMed
    Score: 0.008
  58. Astrocyte regulation of synaptic signaling in psychiatric disorders. Neuropsychopharmacology. 2023 01; 48(1):21-36.
    View in: PubMed
    Score: 0.008
  59. The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders. CNS Drugs. 2022 05; 36(5):451-482.
    View in: PubMed
    Score: 0.008
  60. Cannabinoid use is enhanced by stress and changes conditioned stress responses. Neuropsychopharmacology. 2022 04; 47(5):1037-1045.
    View in: PubMed
    Score: 0.008
  61. Extrasynaptic therapeutic targets in substance use and stress disorders. Trends Pharmacol Sci. 2022 01; 43(1):56-68.
    View in: PubMed
    Score: 0.007
  62. Drug addiction: to the cortex.and beyond! Am J Psychiatry. 2001 Mar; 158(3):349-50.
    View in: PubMed
    Score: 0.007
  63. Circuit selectivity in drug versus natural reward seeking behaviors. J Neurochem. 2021 06; 157(5):1450-1472.
    View in: PubMed
    Score: 0.007
  64. A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol. BMC Psychiatry. 2020 08 06; 20(1):397.
    View in: PubMed
    Score: 0.007
  65. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl). 2000 Aug; 151(2-3):99-120.
    View in: PubMed
    Score: 0.007
  66. Involvement of the pallidal-thalamocortical circuit in adaptive behavior. Ann N Y Acad Sci. 1999 Jun 29; 877:64-70.
    View in: PubMed
    Score: 0.006
  67. Targeting redox regulation to treat substance use disorder using N-acetylcysteine Eur J Neurosci. 2019 08; 50(3):2538-2551.
    View in: PubMed
    Score: 0.006
  68. Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend. 1998 Jun-Jul; 51(1-2):141-53.
    View in: PubMed
    Score: 0.006
  69. A role for sensitization in craving and relapse in cocaine addiction. J Psychopharmacol. 1998; 12(1):49-53.
    View in: PubMed
    Score: 0.006
  70. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev. 1997 Oct; 25(2):192-216.
    View in: PubMed
    Score: 0.006
  71. Abstinence From Drug Dependence After Bilateral Globus Pallidus Hypoxic-Ischemic Injury. Biol Psychiatry. 2016 11 01; 80(9):e79-e80.
    View in: PubMed
    Score: 0.005
  72. The effects of N-Acetylcysteine on frontostriatal resting-state functional connectivity, withdrawal symptoms and smoking abstinence: A double-blind, placebo-controlled fMRI pilot study. Drug Alcohol Depend. 2015 Nov 01; 156:234-242.
    View in: PubMed
    Score: 0.005
  73. Interactions between dopamine and excitatory amino acids in behavioral sensitization to psychostimulants. Drug Alcohol Depend. 1995 Feb; 37(2):95-100.
    View in: PubMed
    Score: 0.005
  74. An open-label pilot trial of N-acetylcysteine and varenicline in adult cigarette smokers. Am J Drug Alcohol Abuse. 2015 Jan; 41(1):52-6.
    View in: PubMed
    Score: 0.004
  75. Potential role of N-acetylcysteine in the management of substance use disorders. CNS Drugs. 2014 Feb; 28(2):95-106.
    View in: PubMed
    Score: 0.004
  76. Metabotropic glutamatergic receptors and their ligands in drug addiction. Pharmacol Ther. 2014 Jun; 142(3):281-305.
    View in: PubMed
    Score: 0.004
  77. A double-blind placebo-controlled trial of N-acetylcysteine in the treatment of cocaine dependence. Am J Addict. 2013 Sep-Oct; 22(5):443-52.
    View in: PubMed
    Score: 0.004
  78. The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal. 2013 Feb 10; 18(5):522-55.
    View in: PubMed
    Score: 0.004
  79. Cellular mechanisms of behavioral sensitization to drugs of abuse. Ann N Y Acad Sci. 1992 Jun 28; 654:128-35.
    View in: PubMed
    Score: 0.004
  80. Translating glutamate: from pathophysiology to treatment. Sci Transl Med. 2011 Sep 28; 3(102):102mr2.
    View in: PubMed
    Score: 0.004
  81. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Brain Res Rev. 1991 Sep-Dec; 16(3):223-44.
    View in: PubMed
    Score: 0.004
  82. Glutamatergic medications for the treatment of drug and behavioral addictions. Pharmacol Biochem Behav. 2012 Feb; 100(4):801-10.
    View in: PubMed
    Score: 0.004
  83. Harnessing neuroplasticity for clinical applications. Brain. 2011 Jun; 134(Pt 6):1591-609.
    View in: PubMed
    Score: 0.004
  84. Extinction circuits for fear and addiction overlap in prefrontal cortex. Learn Mem. 2009 May; 16(5):279-88.
    View in: PubMed
    Score: 0.003
  85. Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Br J Pharmacol. 2008 May; 154(2):327-42.
    View in: PubMed
    Score: 0.003
  86. Is cocaine desire reduced by N-acetylcysteine? Am J Psychiatry. 2007 Jul; 164(7):1115-7.
    View in: PubMed
    Score: 0.003
  87. An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30; 31(2):389-94.
    View in: PubMed
    Score: 0.003
  88. Cystine/glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation. J Neurosci. 2006 Oct 11; 26(41):10514-23.
    View in: PubMed
    Score: 0.003
  89. Homer proteins: implications for neuropsychiatric disorders. Curr Opin Neurobiol. 2006 Jun; 16(3):251-7.
    View in: PubMed
    Score: 0.003
  90. Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals. Am J Addict. 2006 Jan-Feb; 15(1):105-10.
    View in: PubMed
    Score: 0.002
  91. Interactions between neuropeptides and dopamine neurons in the ventromedial mesencephalon. Neurosci Biobehav Rev. 1985; 9(4):573-87.
    View in: PubMed
    Score: 0.002
  92. Behavioral effects of hypothalamic hypophysiotropic hormones, neurotensin, substance P and other neuropeptides. Pharmacol Ther. 1984; 24(1):1-56.
    View in: PubMed
    Score: 0.001
  93. Interactions of neurotensin with brain dopamine systems. Ann N Y Acad Sci. 1982; 400:330-44.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.